CNAs in CCND1, FGF3, FGF4, and FGF19, which are all located in the q-arm of chromosome 11 were more likely to be detected from patients with HR+/HER2+ and HR+/HER2− breast cancer (P < 0.001) (Figure 2). This evidence concerns the gene ERBB2 and breast carcinoma.